INTRODUCTION
============

RPA (replication protein A) is a heterotrimeric complex that functions in DNA replication, repair and recombination pathways in eukaryotes \[[@B1]--[@B4]\]. It consists of three subunits of 70, 32 and 14 kDa respectively, namely RPA1 or RPA70, RPA2 or RPA32, and RPA3 or RPA14 (known as Rfa1, Rfa2 and Rfa3 respectively in *Saccharomyces cerevisiae*) \[[@B1],[@B3]--[@B6]\]. RPA1 consists of four OB (oligonucleotide-binding) fold DBDs (DNA-binding domains), named DBD-F, DBD-A, DBD-B and DBD-C \[[@B3],[@B4]\]. The N-terminal DBD-F and DBD-A domains of RPA1 have been implicated in the recruitment of other factors during DNA replication, repair or recombination \[[@B7]--[@B9]\], whereas the C-terminal DBD-C domain is essential for RPA trimerization \[[@B3],[@B4],[@B10],[@B11]\]. RPA2 contains a flexible NTD (N-terminal domain) that is highly phosphorylated, a DBD, DBD-D, and a CTD (C-terminal domain) that mediates protein--protein interactions \[[@B3],[@B12]--[@B15]\]. RPA3 contains a single DBD, DBD-E, which interacts with DBD-D of RPA2 and DBD-C of RPA1 to form a stable RPA trimer.

The RPA heterotrimeric complex has a high affinity for ssDNA (single-stranded DNA) in a 5′→3′ polar manner \[[@B16]--[@B22]\]. It binds to ssDNA ranging from 8 to 30 nt \[[@B11]\], seemingly with low sequence specificity. DBD-A and DBD-B of RPA1 have the highest DNA-binding affinities \[[@B3],[@B21]\]. Various binding modes requiring different DBDs in the trimeric RPA have been presented \[[@B3],[@B22]--[@B25]\]. However, distinct from RPA1, DBD-D of RPA2 also interacts with dsDNA (double-stranded DNA) and plays an important role in DNA priming during early DNA replication \[[@B4]\]. Moreover, Dickson et al. \[[@B26]\] showed that an RPA2 DBD-D mutant with compromised DNA-binding activity has little effect on cell viability.

RPA is phosphorylated in a cell-cycle-dependent manner \[[@B27]--[@B29]\]. RPA2 is preferentially phosphorylated, especially at its NTD \[[@B3]--[@B5]\]. RPA2 is phosphorylated at Ser^23^ in S-phase, and simultaneously at Ser^23^ and Ser^29^ in M-phase \[[@B30]\]. Phosphorylated RPA2 extracted from mitotic HeLa cells resulted in lower dsDNA-binding affinity, but had no effect on ssDNA binding \[[@B31]\]. RPA2 phosphorylation also abolished its binding to DNA replication and repair proteins such as ATM (ataxia telangiectasia mutated), DNA-PK (DNA-dependent protein kinase) and DNA polymerase α \[[@B31]\]. Furthermore, phosphorylated RPA also showed weaker RPA1--RPA2 interactions \[[@B32]\]. In addition, DNA damage is another key factor triggering RPA hyperphosphorylation, which is, however, distinct from the cell-cycle-dependent phosphorylation. Ionizing radiation led to RPA2 localization to DNA damage loci and RPA2 hyperphosphoryation which involves ATM and DNA-PK \[[@B30]\]. Bleomycin-treated cells undergoing mitosis led to RPA2 phosphorylation at Ser^4^/Ser^8^ and Thr^21^ which are primed by phosphorylation at Ser^23^ and Ser^29^ \[[@B33],[@B34]\]. Ser^4^ and Ser^8^ was demonstrated to be phosphorylated during DSB (double-strand break) of DNA leading to stalled DNA replication \[[@B13],[@B35]--[@B37]\]. Furthermore, RPA2 was shown to be phosphorylated at Ser^11^, Ser^12^, Ser^13^, Thr^21^, Ser^23^, Ser^29^ and Ser^33^ by ATM and DNA-PK *in vitro*, many of which coincide with those phosphorylated *in vivo* in response to DNA damage \[[@B13],[@B36],[@B38]--[@B41]\]. Hence, phosphorylation plays a pivotal role in regulating RPA activity \[[@B39],[@B42]\]. Currently, studies of the phosphatases involved in the phosphoregulation of RPA2 are limited. The PP2A-like phosphatases PP2AC and PP4C have been implicated in dephosphorylating RPA2 in the DNA-damage response \[[@B43],[@B44]\]. However, the phosphatase(s) responsible for RPA2 dephosphorylation during G~1~-phase remains elusive \[[@B43],[@B44]\].

In the present study, we found that the Pph3--Psy2 phosphatase complex is responsible for Rfa2 dephosphorylation both during normal G~1~-phase and under DNA replication stress in *Candida albicans*. Moreover, the results of the present study showed that the domain of Rfa2 phosphorylated during G~1~-phase differed from that phosphorylated in response to DNA replication stress, indicating that differential phosphorylation plays a crucial role in RPA regulation in *C. albicans*.

MATERIALS AND METHODS
=====================

Strains and culture conditions
------------------------------

All *C. albicans* strains used in the present study are listed in Supplementary Table S1 (at <http://www.BiochemJ.org/bj/449/bj4490673add.htm>). Except where noted, *C. albicans* were routinely grown at 30°C in YPD medium (1% yeast extract, 2% peptone and 2% glucose), in GMM (glucose minimal medium; 2% glucose and 6.79 g/l yeast nitrogen base without amino acids) or in GMM supplemented with the required nutrients for auxotrophic mutants. Solid media contained 2% agar.

Preparation of G~1~ cells, induction of hyphal growth by serum and HU (hydroxyurea) treatment of cells
------------------------------------------------------------------------------------------------------

G~1~ cells were obtained by growing yeast cultures at 30°C for 72 h until \>90% of cells were found in G~1~-phase under the microscope. Then the cells were released into fresh YPD medium as described previously \[[@B45]\].

For hyphal growth, bovine serum was added to *C. albicans* yeast cells in YPD medium to a final concentration of 20% and the cells were incubated at 37°C for 4 h before harvesting the cells for analysis.

To cause DNA replication stress, HU was added to *C. albicans* cultures in YPD medium to a final concentration of 20 mM, and the cells were incubated at 30°C for a specified time. Recovery from the DNA replication stress was achieved by shifting the cells to fresh HU-free YPD medium and incubation at 30°C for 4--6 h before harvesting cells for analysis.

Construction of *C. albicans* mutant strains
--------------------------------------------

*C. albicans* homologues of *S. cerevisiae* genes were identified by sequence alignment in the *C. albicans* genome database (<http://www.candidagenome.org>). *C. albicans* deletion mutants were constructed by sequentially deleting the two copies of the target gene with two deletion cassettes from the WT (wild-type) strain of BWP17. The deletion cassettes were constructed by flanking a selectable marker gene (*ARG4* or *HIS1*) with the AB and CD DNA fragments (\~400 bp each), which correspond to the 5′ and 3′ UTRs (untranslated regions) of the target gene respectively \[[@B45]\]. Homozygous deletion mutants were verified by PCR.

For rescue experiments, the entire ORF (open reading frame) of the target gene, together with its promoter (\~1000 bp), was cloned into the CIp10-based *URA3*-marked plasmid at KpnI and ClaI sites, followed by the *GAL4* 3′ UTR. The construct was linearized with StuI, whose site exists in the RP10 sequence of the plasmid CIp10, and finally introduced into the gene deletion strains \[[@B45]\].

Construction of *C. albicans* strains expressing C-terminal Myc-tagged Rfa2 or truncated Rfa2 fragments was carried out as described previously \[[@B46]\]. C-terminal GFP (green fluorescent protein)-tagged Rfa2 was constructed in the WT *C. albicans* strain as described above. For affinity purification of Rfa2, C-terminal His-tagged full-length Rfa2 was constructed in the WT strain, and *pph3*Δ and *psy2*Δ mutants in a similar fashion.

Protein extraction, Western blotting, protein dephosphorylation and co-IP (co-immunoprecipitation)
--------------------------------------------------------------------------------------------------

To extract proteins, cells were harvested by centrifugation (4000 ***g*** for 5 min at 4°C), and \~100 mg of cell pellet was resuspended in 300 μl of ice-cold RIPA buffer \[50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1% Nonidet P40, 0.5% sodium deoxycholate and 0.1% SDS\]. After adding an equal volume of acid-washed glass beads (Sigma--Aldrich), the cells were lysed by four rounds of 45 s of beating at 5000 rev./min in a MicroSmash MS-100 bead beater (Tomy Medico) with 2 min of cooling on ice between rounds. The supernatant was collected after centrifugation of the cell lysate at 16000 ***g*** for 20 min at 4°C. The protein concentration of the lysate was determined using the bicinchoninic acid protein assay (Galen).

For Western blot analysis, 30 μg of total protein was separated by SDS/PAGE (10% or 12% gels) and transferred on to a PVDF membrane (Millipore). The membrane was immersed in TBST \[TBS (Tris-buffered saline, pH 7.4) containing 0.1% Tween 20\] and 5% non-fat dried skimmed milk for 1 h at room temperature (25°C), followed by primary antibody and secondary antibody conjugated to hydrogen peroxidase or AP (alkaline phosphatase) consecutively for 1 h each, both in TBST containing 1% non-fat dried skimmed milk. The target protein was visualized by using the ECL (enhanced chemiluminescence) system or AP system. Anti-Myc and anti-Cdc28 (cell division cycle 28) (PSTAIRE) antibodies were purchased from Santa Cruz Biotechnology.

Protein dephosphorylation was carried out as described previously \[[@B45]\]. λPPase (lambda phosphatase) was purchased from New England BioLabs (catalogue number P07535).

A co-IP assay was performed by using an anti-Myc antibody to first pull down the Myc-tagged protein. Then co-immunoprecipitated proteins were detected by Western blot analysis with appropriate antibodies as described above.

Protein purification and EMSA (electrophoretic mobility-shift assay)
--------------------------------------------------------------------

WT *C. albicans* and *pph3*Δ and *psy2*Δ mutant cells expressing C-terminal His-tagged full-length Rfa2 were grown in YPD medium at 30°C for 3 days. Cells were harvested, lysed by cell disruption (Avestin) and centrifuged at 20000 ***g*** at 4°C for 30 min. The supernatant was purified on gravity-flow Ni-NTA (Ni^2+^-nitrilotriacetate) columns (Qiagen) followed by anion-exchange chromatography (SourceQ, GE Healthcare) on an Äkta purifier (GE Healthcare). Purified Rfa2 was concentrated by using centrifugal concentration tubes (Amicon, Millipore) until a final concentration of 0.8--1.0 mg/ml was reached.

An EMSA was performed with ssDNA of the sequence 5′-FITCCCCCTCTCCTTCTTGGCCTCTTCCTTCCCC-3′ or dsDNA annealed from complementary strands of the sequences 5′-FITCCCCCTCTCCTTCTTGGCCTCTTCCTTCCCC-3′ and 5′-GGGGAAGGAAGAGGCCAAGAAGGAGAGGGG-3′ using standard protocols. Purified Rfa2 protein was mixed at ratios of 0, 3.12, 6.25 and 12.5 pmol to a constant amount of DNA of 400 pmol in a total reaction mixture of 20 μl and incubated at room temperature for 30 min. All reaction mixtures were loaded on to an 8% TGE (Tris-glycine-EDTA) gel and run at 100 V at 4°C for 1 h.

RESULTS
=======

The Pph3--Psy2 complex is responsible for Rfa2 dephosphorylation during G~1~-phase in *C. albicans*
---------------------------------------------------------------------------------------------------

Human RPA2 was found to be phosphorylated during mitosis and became hyperphosphorylated on DNA damage \[[@B3]--[@B5],[@B31],[@B33]\]. PP2A and PP4 were found to dephosphorylate RPA2 in humans after DNA damage \[[@B43],[@B44]\]. However, the phosphatase responsible for RPA2 dephosphorylation during G~1~-phase remained elusive. In the present study, we found that Pph3, the yeast homologue of PP4, dephosphorylates Rfa2 during G~1~-phase *in vivo* and *in vitro* in *C. albicans*.

Western blot analysis of Rfa2 extracted from WT *C. albicans* G~1~ cells exhibited a dephosphorylated form ([Figure 1](#F1){ref-type="fig"}A). The deletion of *PPH3* or replacement of WT *PPH3* with the catalytic mutant allele *pph3-H112A* led to accumulation of phosphorylated Rfa2 in G~1~ cells ([Figure 1](#F1){ref-type="fig"}A). Furthermore, addition of antibody-purified Pph3 dephosphorylated Rfa2 in *pph3*Δ cell lysate (Supplementary Figure S1 at <http://www.BiochemJ.org/bj/449/bj4490673add.htm>), whereas addition of Pph3-H112A had no such effect ([Figure 1](#F1){ref-type="fig"}B). Similarly, Rfa2 was dephosphorylated by the broad-specificity λPPase in the positive control ([Figure 1](#F1){ref-type="fig"}B). Hence, the results strongly suggest that Pph3 dephosphorylates Rfa2 during G~1~-phase in *C. albicans*.

![Pph3 is responsible for Rfa2 dephosphorylation during G~1~-phase\
(**A**) Western blot analysis of Rfa2 extracted from WT cells (HT1), *pph3*Δ cells (HT2) and *pph3*Δ cells expressing Pph3-H112A (HT29.1) in G~1~-phase. G~1~ cells were obtained by growing cells at 30°C for 3 days until \>90% of the cells were in G~1~-phase. (**B**) Western blot analysis of Rfa2 extracted from WT (HT1) and *pph3*Δ (HT2) G~1~ cells. Pph3 affinity-purified from strain HT28, Pph3-H112A from HT29 or λPPase was used to treat immune-purified Rfa2 *in vitro*. (**C**) Co-IP analysis of Pph3 and Psy2 with Rfa2. *C. albicans* cells co-expressing Pph3--Myc and GFP--Rfa2 (HT26), and those co-expressing Psy2--Myc and GFP--Rfa2 (HT27) were grown as yeast (YF) or hyphae (HF). Cell lysates were prepared for co-IP. IP was performed using an anti-Myc antibody followed by Western blot (WB) analysis with an anti-Myc or anti-GFP antibody. (**D**) Western blot analysis of Rfa2 extracted from WT (HT1), *pph3*Δ (HT2), *psy2*Δ (HT3), *ptc2*Δ (HT4), *glc7/MET3:GLC7* (HT25) and *pph3Δ ptc2*Δ (HT5) cells during G~1~ arrest. To shut down *GLC7* expression in HT25, the medium contained 0.5 mM each of methionine and cysteine. (**E**) Western blot analysis of Rfa2 extracted from WT (HT1), *pph3*Δ (HT2) and *psy2*Δ (HT3) G~1~ cells. *C. albicans* Pph3, human PP2Ac or λPPase was used to treat purified Rfa2 *in vitro*.](bj2012-0952i001){#F1}

In addition, we found that the regulatory subunit Psy2 (corresponding to human PP4R3) of Pph3 is involved in the interaction between Pph3 and Rfa2. Co-IP assays revealed that Rfa2 could be pulled down with Pph3 and Psy2 from both yeast and hyphal cells of *C. albicans* ([Figure 1](#F1){ref-type="fig"}C). Whether both subunits directly interact with Rfa2 has not been investigated. Moreover, Rfa2 displayed a phosphorylated form in both the *pph3*Δ and the *psy2*Δ mutant ([Figure 1](#F1){ref-type="fig"}D). This indicates that Psy2 is required for proper Rfa2 dephosphorylation during G~1~-phase. Further investigations with deletion mutants of *ptc2* and *glc7*, the yeast homologues of PP2C and PP1, demonstrated that the *pph3Δ ptc2*Δ mutant resulted in Rfa2 phosphorylation during G~1~-phase, whereas Rfa2 remained dephosphorylated in *ptc2*Δ and *glc7*Δ cells, similar to WT cells ([Figure 1](#F1){ref-type="fig"}D). In addition, *in vitro* addition of Pph3, human PP2AC or λPPase dephosphorylated Rfa2 immunopurified from *pph3*Δ and *psy2*Δ cell lysates ([Figure 1](#F1){ref-type="fig"}E). Hence, we concluded that Rfa2 is specifically dephosphorylated by the Pph3--Psy2 complex during G~1~-phase in *C. albicans*.

Pph3 is responsible for Rfa2 dephosphorylation under DNA replication stress in *C. albicans*
--------------------------------------------------------------------------------------------

In humans, DNA damage is known to lead to RPA2 hyperphosphorylation in a manner distinct from its phosphorylation during mitosis \[[@B3],[@B4],[@B33],[@B34]\]. We next asked whether Pph3 is involved in Rfa2 dephosphorylation under DNA replication stress in *C. albicans*. Before addressing this question, we first wanted to check whether cell-cycle phases affect Rfa2 phosphorylation, as observed for RPA2 in human cells. We monitored Rfa2 phosphorylation at timed intervals after releasing G~1~ yeast cells into both yeast and hyphal growth conditions. In WT YF (yeast form) cells, Rfa2 was not phosphorylated at time zero, but became phosphorylated between 60 and 120 min, and the phosphorylation started to diminish at 150 min ([Figure 2](#F2){ref-type="fig"}A, top left-hand panel). The results indicated that Rfa2 undergoes cell-cycle-dependent phosphorylation. In HF (hyphal form) WT cells induced by serum at 37°C, Rfa2 phosphorylation was observed after 120 min and started to diminish at 240 min after hyphal induction ([Figure 2](#F2){ref-type="fig"}A, top right-hand panel). In sharp contrast, Rfa2 was persistently phosphorylated in *pph3*Δ mutant cells under both yeast and hyphal growth conditions ([Figure 2](#F2){ref-type="fig"}A, bottom panels).

![Pph3 is responsible for Rfa2 dephosphorylation during normal growth and under DNA replication stress\
(**A**) WT (HT1) and *pph3*Δ (HT2) G~1~ cells were released into conditions for yeast (YF) or hyphal (HF) growth. Aliquots of cells were harvested at the indicated times for Western blot analysis of Rfa2. (**B**) WT (HT1), *pph3*Δ (HT2) and *psy2*Δ (HT3) G~1~ cells were first treated with 20 mM HU and then allowed to recover by transferring cells to HU-free medium for further growth. Aliquots of cells were harvested at the times indicated during both HU treatment and the recovery period for Western blot analysis of Rfa2.](bj2012-0952i002){#F2}

We next tested the effect of the DNA replication inhibitor HU on Rfa phosphorylation. We observed that growing WT yeast cells in the presence of HU resulted in Rfa2 hyperphosphorylation, and subsequent shifting of the cells to HU-free media caused its gradual dephosphorylation ([Figure 2](#F2){ref-type="fig"}B). In contrast, while Rfa2 in *pph3*Δ and *psy3*Δ cells became hyperphosphorylated in response to HU treatment, the level of Rfa2 phosphorylation continued to increase after HU removal ([Figure 2](#F2){ref-type="fig"}B).

Hence, we concluded that Pph3 is responsible for Rfa2 dephosphorylation both during the cell cycle and under HU treatment.

Phosphorylated Rfa2 exhibited diminished binding activity to dsDNA, but not to ssDNA
------------------------------------------------------------------------------------

Oakley et al. \[[@B31]\] showed previously that phosphorylated RPA2 extracted from mitotic human cells had little dsDNA-binding activity, whereas unphosphorylated recombinant RPA2 purified from bacteria exhibited dsDNA-binding activity. In the present study, we discovered that Rfa2 extracted from *pph3*Δ or *psy2*Δ cells also exhibited diminished binding to dsDNA compared with Rfa2 from WT cells in an EMSA ([Figure 3](#F3){ref-type="fig"}A). Consistent with previous studies \[[@B31]\], ssDNA binding of Rfa2 purified from *pph3*Δ or *psy2*Δ cells was unaffected ([Figure 3](#F3){ref-type="fig"}B). Therefore the results of the present study are consistent with the concept that phosphorylation of Rfa2 abolishes its binding to dsDNA, but not ssDNA \[[@B3],[@B4],[@B31]\].

![EMSA of Rfa2 with dsDNA and ssDNA\
(**A**) Top panel: Rfa2 affinity-purified from WT (HT41), *pph3*Δ (HT42) and *psy2*Δ (HT43) cells was incubated with FITC-labelled dsDNA at molar ratios of DNA/protein of 0, 8, 16 and 32 at room temperature for 30 min. The protein/DNA mixture was then resolved by TGE/PAGE (8% gel) and detected by fluorescence at an emission wavelength of 320 nm. Bottom panel: the same amounts of purified Rfa2 as above were resolved by SDS/PAGE (12% gel) as a protein loading control. (**B**) The experiment described above was repeated using ssDNA instead of dsDNA.](bj2012-0952i003){#F3}

Different domains of Rfa2 are (de)phosphorylated under different conditions in *C. albicans*
--------------------------------------------------------------------------------------------

Thr^43^ in DBD-D is the only consensus CDK (cyclin-dependent kinase) phosphorylation site present on *C. albicans* Rfa2. Next, we tried to decipher the sites of phosphorylation on Rfa2 under normal growth conditions and DNA replication inhibition. We examined Rfa2 phosphorylation by Western blot analysis in different kinase-deficient *C. albicans* mutants. We first used a strain expressing the mutant Cdc28-as kinase which can be inhibited by the ATP analogue 1NM-PP1. We found that Rfa2 phosphorylation was not detectable in either YF or HF cells when 1NM-PP1 was added to the cultures. In comparison, Rfa2 phosphorylation was detected to be normal in the *mec1Δ/MET3*-*MEC1* (*MEC1* was shown to decrease by adding methionine and cysteine to the medium), *mrc1*Δ, *rad9*Δ and *ime2*Δ mutants grown under normal growth conditions ([Figure 4](#F4){ref-type="fig"}A, left-hand panel). However, Rfa2 remained dephosphorylated only in the *mec1Δ/MET3*-*MEC1* mutant after HU treatment ([Figure 4](#F4){ref-type="fig"}A, right-hand panel). Moreover, co-IP showed that Cdc28 directly interacted with Rfa2 in both yeast and hyphal cells under normal growth conditions ([Figure 4](#F4){ref-type="fig"}C). However, in spite of repeated efforts, we failed to observe an interaction between Rfa2 and Mec1 in co-IP experiments (results not shown). We cannot rule out the possibility of transient or weak interaction between the proteins. Nevertheless, the results of the present study support a proposal that Cdc28 and Mec1 are responsible for Rfa2 phosphorylation during a normal cell cycle and under HU stress respectively.

![Role of Cdc28 and Mec1 in Rfa2 phosphorylation during normal growth and under HU treatment\
(**A**) Western blot analysis of Rfa2 extracted from WT (HT1), *Cdc28*-*as* (HT40), *mec1*Δ/*MET3-MEC1* (HT37), *mrc1*Δ (HT34), *rad9*Δ (HT35) and *ime2*Δ (HT39) cells in G~1~-phase, yeast growth (YF) and hyphal growth (HF) (left-hand panel) or after HU treatment for 4 h (right-hand panel). The anti-PSTAIRE antibody was used to show that equal amounts of protein were used. (**B**) Co-IP analysis of Cdc28 with Rfa2. Cells expressing Rfa2--Myc (HT1) were grown as yeast (YF) or hyphae (HF) for co-IP analysis. Rfa2 was pulled down with an anti-Myc antibody, followed by Western blot analysis with anti-Myc or anti-PSTAIRE antibodies.](bj2012-0952i004){#F4}

Next, we wanted to determine whether the phosphorylation sites on Rfa2 that occurred during normal growth differ from those induced by HU treatment. First, we constructed two truncated forms of Rfa2: Rfa2-NΔ40 containing residues 41--272 and Rfa2-CΔ182 containing residues 1--190 ([Figure 5](#F5){ref-type="fig"}A). We then expressed the two truncated versions of Rfa2 in WT and *pph3*Δ cells under normal growth conditions and HU treatment. The phosphorylation status of the two truncated Rfa2 proteins was examined by Western blot analysis in comparison with the FL (full-length) WT Rfa2 (Rfa2-FL). The results showed that in WT cells both truncated forms of Rfa2 were dephosphorylated during G~1~-phase ([Figure 5](#F5){ref-type="fig"}B, lanes 1, 5 and 9) and became phosphorylated 90 min after release ([Figure 5](#F5){ref-type="fig"}B, lanes 2, 6 and 10). In contrast, Rfa2-FL, Rfa2-NΔ40 and Rfa2-CΔ182 expressed in the *pph3*Δ mutant cells were phosphorylated during G~1~ arrest ([Figure 5](#F5){ref-type="fig"}B, lanes 3, 7 and 11), and the phosphorylation persisted at 90 min ([Figure 5](#F5){ref-type="fig"}B, lanes 4, 8 and 12). Therefore these results demonstrated that: (i) unlike the predominant phosphorylation of RPA2 in the NTD reported in previous studies \[[@B13],[@B36],[@B38]--[@B41]\], the NTD of Rfa2 is not the only domain phosphorylated during normal growth in *C. albicans*; and (ii) Pph3 is responsible for dephosphorylating Rfa2 during G~1~-phase.

![Different domains on Rfa2 are (de)phosphorylated under different circumstances\
(**A**) Schematic description of FL and truncated versions of Rfa2. Rfa2-FL (HT1 and HT2), Rfa2-CΔ182 (HT31 and HT33) containing residues 1--190 and Rfa2-NΔ40 (HT30 and HT32) containing residues 41--272 were expressed in WT or *pph3*Δ (SJL2) mutant cells. (**B**) Western blot analysis of Rfa2 extracted from WT (HT1, HT30 and HT31) and *pph3*Δ (HT2, HT32 and HT33) cells expressing different versions of Rfa2 in G~1~-phase and after release. An anti-PSTAIRE antibody was used to detect Cdc28 as a loading control. (**C**) Western blot analysis of Rfa2 extracted from the same set of cells as above during G~1~-phase and after HU treatment.](bj2012-0952i005){#F5}

Next, Western blot analysis of HU-treated WT and *pph3*Δ cells expressing Rfa2-FL, Rfa2-NΔ40 and Rfa2-CΔ182 showed that Rfa2-FL and Rfa2-CΔ182, but not Rfa2-NΔ40, became phosphorylated in WT cells ([Figure 5](#F5){ref-type="fig"}C, lanes 2, 6 and 8), whereas all three proteins were phosphorylated in *pph3*Δ cells ([Figure 5](#F5){ref-type="fig"}C, lanes 4, 8 and 12). Therefore we observed that Rfa2-NΔ40 containing the DBD-D and CTDs existed in dephosphorylated form in WT, but not *pph3*Δ, cells after HU treatment in *C. albicans*. We deduced that the persistent phosphorylation of Rfa2-NΔ40 in *pph3*Δ cells before and after HU treatment ([Figure 5](#F5){ref-type="fig"}C, lanes 11 and 12) might reflect the background level of phosphorylation as seen in normal cells ([Figure 5](#F5){ref-type="fig"}B, lanes 11 and 12). Hence, this result suggests that the NTD is involved in response to DNA replication stress.

Next, we tried to map phosphorylation sites on Rfa2 extracted from *pph3*Δ mutant cells under normal growth conditions by MS. Results showed that the only consensus CDK phosphorylation site, Thr^43^, was phosphorylated ([Figure 6](#F6){ref-type="fig"}A). Additionally, Ser^146^ and Ser^153^ were two other phosphorylation sites with the highest probabilities ([Figure 6](#F6){ref-type="fig"}A). Eight other potential phosphorylation sites, Thr^24^, Thr^34^/Thr^35^/Thr^36^, Ser^148^, Ser^211^, Thr^213^ and Ser^247^, were also identified ([Table 1](#T1){ref-type="table"}). Sequence alignment of these potential phosphorylation sites of *C. albicans* Rfa2 with RPA2 in human, mouse, frog and zebrafish revealed little homology. However, Thr^43^ of *C. albicans* Rfa2 is conserved with Thr^40^ in *S. cerevisiae* Rfa2 ([Figure 6](#F6){ref-type="fig"}B).

![Potential dephosphoryation sites on Rfa2 mediated by Pph3 during normal growth\
(**A**) Domain structure of Rfa2 depicting potential dephosphorylation sites mediated by Pph3. Rfa2 extracted from *pph3*Δ (HT2) cells was subject to MS analysis to map potential dephosphorylation sites mediated by Pph3 during normal growth phase. A black square denotes theoretical phosphorylation sites listed on the Uniprot database; a black triangle denotes phosphorylated sites mapped by MS with medium-high probability; and a black circle denotes phosphorylated sites mapped by MS with high probability. (**B**) Sequence alignment of Rfa2 and homologues in *Homo sapiens*, *Mus musculus*, *Xenopus laevis*, *Danio rerio*, *S. cerevisiae* and *C. albicans*. The secondary structure of human RPA2 (PDB codes 2PQA and 1Z1D) is illustrated above the sequence, where wave lines denotes α-helix, arrows denote β-strand, loops denote turns and broken lines denote unstructured regions. Black squares denote empirical DNA-PK and PI3K phosphorylation sites on human RPA2; black triangles denote CDK phosphorylation sites on human RPA2; and the black circle denotes the phospho-threonine mapped on *C. albicans* Rfa2 in the present study.](bj2012-0952i006){#F6}

###### MS mapping of phosphorylation sites in Rfa2

Phosphorylation site mapping by tandem MS. Asterisks indicate phosphoserine or phosphothreonine residues. Consensus CDK phosphorylation sites are underlined.

  Sequence of identified peptide        Position of phospho-residues
  ------------------------------------- --------------------------------------------------
  SQGGFNT\*EHAGSSQRQ                    Thr^24^
  RQT\*T\*TQVRQ                         Thr^34^, Thr^35^
  RQSL[T\*P]{.ul}VTIKQ                  Thr^43^
  RQSL[T\*P]{.ul}VT\*IKQ                Thr^43^, Thr^46^
  RQS\*L[T\*P]{.ul}VTIKQ                Ser^41^,Thr^43^
  TTQVRQSL[T\*P]{.ul}VTIKQ              Thr^43^
  RQTTT\*QVRQSL[T\*P]{.ul}VTIKQ         Thr^36^, Thr^43^
  RQTTT\*QVRQSL[T\*P]{.ul}VT\*IKQ       Thr^36^, Thr^43^, Thr^46^
  KTVQNASIS\*LIT                        Ser^148^
  RKTVQNASISLITDS\*NQI                  Ser^153^
  KT\*VQNAS\*ISLITDSNQIVYHHLSAIEHHLKA   Thr^141^, Ser^146^
  KEES\*QFQLLKL                         Ser^247^
  RTMPDGVPVDYVAEKLSITKEES\*QFQLLKL      Ser^247^
  KDTGS\*LT\*DQVIAVLKE                  Ser^211^, Thr^213^
  KAYAGYDDNS\*YLVIEQKL                  Ser^268^
  KYNEMKGKYVYVGGS\*LKQFNNRK             Ser^132^
  KAQGITAADAASAGAGQATNSTAS\*AGS\*       Ser^192^, Ser^195^, Thr^203^, Ser^204^, Ser^206^
  GLFMDNPT\*S\*LS\*KD                   

Finally, we performed alanine mutagenesis on the most probable phosphorylation sites occurring in different domains of Rfa2 identified by MS ([Table 1](#T1){ref-type="table"}) and investigated the phosphorylation state of these mutant proteins in G~1~ cells and cells treated with HU. Western blot analysis showed that the Rfa2-T43A/S146A/S153A mutant remained unphosphorylated in G~1~ cells ([Figure 7](#F7){ref-type="fig"}A), but not in HU-treated cells ([Figure 7](#F7){ref-type="fig"}B). This observation is consistent with our finding that domains other than the NTD is phosphorylated in G~1~-phase ([Figure 5](#F5){ref-type="fig"}B), and suggests that Thr^43^, Ser^146^ and Ser^153^ in the DBD may play a critical role in a normal cell cycle. Ser^18^ and Ser^30^ in the NTD were predicted to be DNA-PK and PI3K (phosphoinositide 3-kinase) phosphorylation sites. We found that the Rfa2-S18A/S30A mutant showed significantly reduced phosphorylation on HU treatment ([Figure 7](#F7){ref-type="fig"}B), confirming that the NTD, but not other domains, is essentially involved in Rfa2 phosphorylation under HU treatment ([Figure 5](#F5){ref-type="fig"}C). The observation that the level of Rfa2-S18A/S30A phosphorylation was comparable with WT Rfa2 in G~1~-phase ([Figure 7](#F7){ref-type="fig"}A) further supports our finding that domains other than the NTD were phosphorylated during G~1~-phase ([Figure 5](#F5){ref-type="fig"}B). Furthermore, the Rfa2-S211A/T213A/S247A mutant showed a similar level of phosphorylation to WT Rfa2 both in G~1~-phase ([Figure 7](#F7){ref-type="fig"}A) and under HU treatment ([Figure 7](#F7){ref-type="fig"}B), suggesting that the CTD plays a minor role in Rfa2 phosphoregulation. Other mutants manifested similar phosphorylation patterns as WT Rfa2. It is to be noted that the mutant Rfa2 (Rfa2-12A) with all 12 selected sites of Ser^18^, Ser^30^, Thr^24^, Thr^34^, Thr^35^, Thr^36^, Thr^43^, Ser^146^, Ser^153^, Ser^211^, Thr^213^ and Ser^247^ mutated to alanine, remained unphosphorylated in G~1~-phase in both *pph3*Δ and *psy2*Δ mutants ([Figure 7](#F7){ref-type="fig"}A) and on HU treatment in WT cells ([Figure 7](#F7){ref-type="fig"}B), indicating that these sites are determinant for Rfa2 phosphorylation collectively. Taken together, these results support the idea that domains of Rfa2 that are (de)phosphorylated during a normal cell cycle are different from those phosphorylated in response to DNA replication stress in *C. albicans*.

![Identification of Rfa2 phosphorylation sites under different circumstances\
(**A**) Western blot analysis of Rfa2 in *pph3*Δ (HT2, HT45, HT48, HT51, HT54 and HT57) and *psy2*Δ (HT3, HT46, HT49, HT52, HT55 and HT58) cells expressing different serine/threonine mutant alleles of *RFA2* in G~1~ cells. An anti-PSTAIRE antibody was used to probe Cdc28 as a loading control. (**B**) Western blot analysis of Rfa2 in WT (HT1, HT44, HT47, HT50, HT53 and HT56) cells expressing different serine/threonine mutant alleles of *RFA2* before and after HU treatment.](bj2012-0952i007){#F7}

DISCUSSION
==========

Pph3 dephosphorylates Rfa2 during G~1~-phase and HU treatment
-------------------------------------------------------------

In the present study, we found that the Pph3--Psy2 complex is responsible for Rfa2 dephosphorylation during G~1~-phase and on HU treatment. However, it was reported that PP4R2, but not PP4R3 (corresponding to Psy4 and Psy2 respectively in yeast) mediated RPA2 dephosphorylation in humans \[[@B44]\]. Although we could not rule out a role for Psy4 in Rfa2 dephosphorylation in *C. albicans*, the results of the present study clearly demonstrated that, distinct from humans, Psy2 is required for Rfa2 dephosphorylation. Further studies on other regulatory subunits of Pph3 need to be carried out to determine whether other Pph3 complexes have a role in the regulation of Rfa2 dephosphorylation.

We also showed that Rfa2 extracted from *pph3*Δ cells exhibited diminished binding to dsDNA, but not ssDNA, a result consistent with reports by Oakley et al. \[[@B31]\]. However, Patrick et al. \[[@B47]\] showed that phosphorylated RPA2 binds more weakly to short ssDNA (8--11 nt), but not long ssDNA. In the present study, the length of ssDNA used was 30 nt and, therefore, our EMSA result is not contradictory to previous observations.

Rfa2 regulation involves differential phosphorylation of different domains
--------------------------------------------------------------------------

Different kinases have been inferred in Rfa2 phosphorylation. For instance, in human cells, the CDK Cdc2 was shown to phosphorylate RPA2 during S-phase \[[@B29]\], and Mec1 was implicated in RPA2 hyperphosphorylation during HU treatment \[[@B48]\]. In *S. cerevisiae*, the meiosis-specific kinase Ime2 was found to be an Rfa2 kinase \[[@B49]\] which was shown to phosphorylate Ser^27^ of Rfa2 in a distinct manner from the mitotic Cln2--Cdk1 complex \[[@B50]\]. In addition to phosphorylation, previous studies have also shown that the phosphatase PP2A dephosphorylates Thr^21^ and Ser^33^ of RPA2 to trigger DNA-repair pathways in response to HU treatment in humans \[[@B43]\], and that PP4 was responsible for RPA2 dephosphorylation triggered by DNA DSBs induced by camptothecin \[[@B44]\]. Thus differential phosphorylation is prevalent in RPA2 under different conditions.

Human RPA2 is phosphorylated during mitosis \[[@B31],[@B33]\]. Ser^23^ and Ser^29^ in human RPA2 are two consensus CDK phosphorylation sites (SP/TP) which are conserved from zebrafish to humans ([Figure 6](#F6){ref-type="fig"}B, black triangle); however, these two SP/TP sites are not conserved in plants such as *Arabidopsis thaliana* or yeast such as *S. cerevisiae* or *C. albicans*. We noticed that Thr^43^ in *C. albicans* Rfa2 (corresponding to Thr^40^ in *S. cerevisiae*) is the sole predicted CDK site that aligns to a conserved valine--proline site in RPA2 of higher eukaryotes ([Figure 6](#F6){ref-type="fig"}B, black circle). In the present study, MS indicated that Thr^43^ was phosphorylated in *pph3*Δ mutant cells, which replicated slightly faster than WT cells under unperturbed conditions (Supplementary Figure S2 at <http://www.BiochemJ.org/bj/449/bj4490673add.htm>), but lost viability more rapidly than WT cells in response to genotoxic stress \[[@B46]\]. In support of this observation, the Rfa2-T43A/S146A/S153A triple mutant remained unphosphorylated in G~1~-phase in both *pph3*Δ and *psy2*Δ cells ([Figure 7](#F7){ref-type="fig"}A). Although the results of the present study suggest that mutating Thr^43^, Ser^146^ and Ser^153^ is sufficient to block Rfa2 phosphorylation during G~1~-phase, single-residue mutation is necessary to delineate the role of each residue. Nevertheless, the results of the present study support the notion that the DBD which harbours these residues is phosphorylated during G~1~-phase ([Figures 5](#F5){ref-type="fig"}B, [6](#F6){ref-type="fig"}A and [7](#F7){ref-type="fig"}A). Sequence identities of *C. albicans* Rfa2 to human, mouse, *Xenopus* and zebrafish RPA2 are 22.7, 23.1, 23.7 and 20.4% respectively, compared with a slightly higher identity of 29.4% to *S. cerevisiae* Rfa2, where homology mainly exists in their DBDs. In this context, it is hard to predict whether phosphorylation in regions other than the NTD of RPA2 occurs in other eukaryotes. Currently, reports on RPA2 are limited in other organisms. Hence, we do not know whether this phenomenon is unique in *C. albicans*.

Under certain stress conditions, many sites were shown to be phosphosphorylated in human RPA2 \[[@B13],[@B35]--[@B41]\] ([Figure 6](#F6){ref-type="fig"}B, black square), and the majority of these sites were found to be located in the NTD. Among these sites, Ser^18^ and Ser^30^ in *C. albicans* Rfa2 (corresponding to Thr^21^ and Ser^33^ in human RPA2) are conserved. The results of the present study show that, on HU treatment, Rfa2-FL and Rfa2-CΔ182 became phosphorylated, whereas Rfa2-NΔ40 remained dephosphorylated in WT cells, indicating possible phosphorylation in the NTD in *C. albicans* Rfa2 after HU treatment. Mutagenesis on Ser^18^ and Ser^30^ demonstrated that these sites partially contribute to Rfa2 phosphorylation during HU treatment ([Figure 7](#F7){ref-type="fig"}B). Therefore we speculate that regulation of Rfa2 phosphorylation in *C. albicans* upon HU treatment also occurs in its NTD, similar to humans.

In summary, the present study has shown that: (i) the Pph3--Psy2 complex is responsible for Rfa2 dephosphorylation both during G~1~-phase and under DNA replication stress in *C. albicans*; and (ii) different domains of Rfa2 are (de)phosphorylated under different circumstances.

Online data
===========

###### Supplementary data

AUTHOR CONTRIBUTION
===================

Haitao Wang, Ada Wong, Jianli Sang and Yue Wang conceived and designed the experiments. Haitao Wang, Jiaxin Gao and Kangdi Hu performed the experiments. Haitao Wang, Ada Wong, Jianli Sang, Wanjie Li and Yue Wang analysed the data. Ada Wong, Yue Wang and Haitao Wang wrote the paper.

ACKNOWLEDGEMENTS
================

We thank members of the Sang laboratory for comments and suggestions on the paper before submission.

FUNDING
=======

This work was supported by the National Basic Research Program of China \[grant number 2007CB914401\], the National Natural Science Foundation of China \[grant number 31270113\] and the Fundamental Research Funds for the Central Universities \[grant number 105566GK\].

[^1]: ^1^These authors contributed equally to this work.
